January 04, 2013
1 min read
Save

Phaco outperforms laser iridotomy at 2 years in acute primary angle closure

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Phacoemulsification and IOL implantation were more effective than laser peripheral iridotomy at 2 years in managing acute primary angle closure and concomitant cataract, according to a study.

Perspective from Thomas W. Samuelson, MD

The randomized controlled trial included 18 patients who underwent laser peripheral iridotomy and 19 patients who underwent phacoemulsification and IOL implantation.

All patients underwent Goldmann applanation tonometry, gonioscopy and corneal endothelial cell count measurements at 3, 6, 12 and 24 months after surgery.

There were seven failures (38.9%) in the laser peripheral iridotomy group and two failures (10.5%) in the phacoemulsification group at 2 years; the between-group difference was statistically significant (P = .029).

The 2-year cumulative survival rate was 61.1% in the laser peripheral iridotomy group and 89.5% in the phacoemulsification group; the difference was significant (P = .034).